These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10494233)

  • 1. Prostate cancer testing: behaviour, motivation and attitudes among Western Australian men.
    Slevin TJ; Donnelly N; Clarkson JP; English DR; Ward JE
    Med J Aust; 1999 Aug; 171(4):185-8. PubMed ID: 10494233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
    Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
    BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do men refuse or attend population-based screening for prostate cancer?
    Nijs HG; Essink-Bot ML; DeKoning HJ; Kirkels WJ; Schröder FH
    J Public Health Med; 2000 Sep; 22(3):312-6. PubMed ID: 11077903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pros and cons of prostate cancer screening: associations with screening knowledge and attitudes among urban African American men.
    Davis SN; Diefenbach MA; Valdimarsdottir H; Chen T; Hall SJ; Thompson HS
    J Natl Med Assoc; 2010 Mar; 102(3):174-82. PubMed ID: 20355346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitudes and experience associated with testing for prostate cancer: a comparison between male doctors and men in the community.
    Livingston P; Cohen P; Frydenberg M; Borland R; Reading D; Clarke V; Hill D
    Intern Med J; 2002; 32(5-6):215-23. PubMed ID: 12036219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016.
    Molazem Z; Ebadi M; Khademian M; Zare R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):633-637. PubMed ID: 29580031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study.
    Pinnock CB; Weller DP; Marshall VR
    Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.
    Mercer SL; Goel V; Levy IG; Ashbury FD; Iverson DC; Iscoe NA
    Can J Public Health; 1997; 88(5):327-32. PubMed ID: 9401168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS.
    Weller D; Pinnock C; Silagy C; Hiller JE; Marshall VR
    Aust N Z J Public Health; 1998; 22(3 Suppl):400-2. PubMed ID: 9629831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
    McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
    BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.
    Morlando M; Pelullo CP; Di Giuseppe G
    PLoS One; 2017; 12(10):e0186332. PubMed ID: 29023514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial of prostate cancer screening in The Netherlands: assessment of acceptance and motives for attendance.
    Nijs HG; Tordoir DM; Schuurman JH; Kirkels WJ; Schröder FH
    J Med Screen; 1997; 4(2):102-6. PubMed ID: 9275269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Being screened for prostate cancer: a simple blood test or a commitment to treatment?
    Oliffe J
    Cancer Nurs; 2006; 29(1):1-8. PubMed ID: 16557114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
    Gattellari M; Ward JE
    J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: a study from the National Prostate Cancer Register (NPCR) of Sweden.
    Fridriksson J; Gunseus K; Stattin P
    Scand J Urol Nephrol; 2012 Oct; 46(5):326-31. PubMed ID: 22647143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitudes, and screening practices among older men regarding prostate cancer.
    Steele CB; Miller DS; Maylahn C; Uhler RJ; Baker CT
    Am J Public Health; 2000 Oct; 90(10):1595-600. PubMed ID: 11029994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.